PL1754478T3 - Ciekła kompozycja zawierająca argininę i kwas α-liponowy, oraz jej zastosowanie do poprawy sprawności seksualnej - Google Patents

Ciekła kompozycja zawierająca argininę i kwas α-liponowy, oraz jej zastosowanie do poprawy sprawności seksualnej

Info

Publication number
PL1754478T3
PL1754478T3 PL05107206T PL05107206T PL1754478T3 PL 1754478 T3 PL1754478 T3 PL 1754478T3 PL 05107206 T PL05107206 T PL 05107206T PL 05107206 T PL05107206 T PL 05107206T PL 1754478 T3 PL1754478 T3 PL 1754478T3
Authority
PL
Poland
Prior art keywords
improvement
sexual function
arginine
lipoic acid
alpha
Prior art date
Application number
PL05107206T
Other languages
English (en)
Inventor
Klaus Wessel
Original Assignee
Encrypta Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encrypta Gmbh filed Critical Encrypta Gmbh
Publication of PL1754478T3 publication Critical patent/PL1754478T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL05107206T 2005-08-04 2005-08-04 Ciekła kompozycja zawierająca argininę i kwas α-liponowy, oraz jej zastosowanie do poprawy sprawności seksualnej PL1754478T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05107206A EP1754478B1 (en) 2005-08-04 2005-08-04 Liquid Composition comprising arginine and alpha-lipoic acid and its use for improvement of sexual function

Publications (1)

Publication Number Publication Date
PL1754478T3 true PL1754478T3 (pl) 2009-07-31

Family

ID=35502745

Family Applications (2)

Application Number Title Priority Date Filing Date
PL05107206T PL1754478T3 (pl) 2005-08-04 2005-08-04 Ciekła kompozycja zawierająca argininę i kwas α-liponowy, oraz jej zastosowanie do poprawy sprawności seksualnej
PL06776605T PL1909782T3 (pl) 2005-08-04 2006-08-04 Kompozycje obejmującej argininę i kwas R-alfa-liponowy i ich zastosowanie do poprawiania funkcji seksualnych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL06776605T PL1909782T3 (pl) 2005-08-04 2006-08-04 Kompozycje obejmującej argininę i kwas R-alfa-liponowy i ich zastosowanie do poprawiania funkcji seksualnych

Country Status (17)

Country Link
US (1) US9107889B2 (pl)
EP (2) EP1754478B1 (pl)
JP (3) JP5295766B2 (pl)
CN (2) CN102670591B (pl)
AT (1) ATE418976T1 (pl)
BR (1) BRPI0614434B8 (pl)
CY (2) CY1109430T1 (pl)
DE (1) DE602005012089D1 (pl)
DK (2) DK1754478T3 (pl)
ES (2) ES2320560T3 (pl)
MX (1) MX2008001554A (pl)
PL (2) PL1754478T3 (pl)
PT (2) PT1754478E (pl)
RU (1) RU2423120C2 (pl)
SI (2) SI1754478T1 (pl)
UA (1) UA95917C2 (pl)
WO (1) WO2007017191A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1754478E (pt) * 2005-08-04 2009-03-31 Encrypta Gmbh Composição líquida compreendendo arginina e ácido alfalipóico e sua utilização para melhorar a função sexual
FR2939042B1 (fr) * 2008-11-28 2010-11-26 Oreal PROCEDE DE DEPIGMENTATION DES MATIERES KERATINIQUES A l'AIDE DE COMPOSES DITHIOLANNES.
RU2458537C1 (ru) * 2011-03-14 2012-08-20 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики эректильной дисфункции у мужчин
FR3012039A1 (fr) * 2013-10-22 2015-04-24 Philippe Olivier Gorny Medicament ou produit dietetique et son utilisation pour prevenir ou traiter les dysfonctionnements sexuels de l'homme et de la femme
DK180173B1 (en) 2018-12-07 2020-07-14 Inxo Ivs Compositions for improving sexual function
US11571405B2 (en) 2018-12-07 2023-02-07 Inxo A/S Compositions for improving sexual function
CN109876194B (zh) * 2019-04-11 2021-04-02 湖北大学 一种可调节降解速率的poss-peg杂化水凝胶及其制备方法和其应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0089126B1 (en) 1982-03-15 1986-07-30 Imperial Chemical Industries Plc Process of oxidising hydrocarbons
DE3629116A1 (de) * 1986-08-27 1988-03-10 Asta Pharma Ag Verfahren zur herstellung enantiomerenreiner r-(+)-(alpha)-liponsaeure und s-(-)-(alpha)-liponsaeure (thioctsaeure) sowie nonen- beziehungsweise mesylderivate als zwischenprodukte hierfuer
ES2038733T3 (es) 1987-12-04 1993-08-01 Asta Medica Ag Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
DE3840076A1 (de) 1987-12-04 1989-06-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
DE4035442B4 (de) 1989-11-09 2010-04-29 Evonik Degussa Gmbh Arzneimittel enthaltend als Wirkstoff R-α-Liponsäure
DE4137773A1 (de) 1991-11-16 1993-05-19 Degussa Herstellung und verwendung von salzen der reinen enantiomere der (alpha)-liponsaeure
JP2684287B2 (ja) * 1991-12-20 1997-12-03 株式会社河合楽器製作所 楽器自動演奏装置
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
DE4317646A1 (de) 1993-05-27 1994-12-01 Asta Medica Ag Tabletten mit Thioctsäure und mindestens einer basischen Komponente
DE4433764A1 (de) 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
US6234176B1 (en) 1996-06-21 2001-05-22 Integrated Medical Systems, Inc. Data logger for transportable life support system
US7504376B2 (en) * 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
US6387645B1 (en) * 1998-07-16 2002-05-14 Hyseq, Inc. Methods and materials relating to novel CD39-like polypeptides
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
US6207190B1 (en) * 1998-08-13 2001-03-27 Chronorx, Llc Dosage forms for the treatment of the chronic glaucomas
FR2791571B1 (fr) 1999-04-02 2002-10-04 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
AR042572A1 (es) 1999-04-02 2005-06-29 Sod Conseils Rech Applic Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos
ES2162586B1 (es) 1999-11-25 2002-07-01 Moraleda Manuel Gomez Composicion que comprende aceites ozonizados y/o otros productos naturales y/o sinteticos ozonizados, y su empleo en composiciones farmaceuticas, cosmeticas, dieteticas o de suplementos alimentarios, en los campos humano y veterinario
CZ20022927A3 (cs) * 2000-02-01 2003-06-18 Muscletech Research And Development Inc. Doplňky stravy založené na alfa-lipoové kyselině pro zvýšení čisté svalové hmoty a síly
US6387945B2 (en) 2000-04-11 2002-05-14 The Regents Of The University Of California Lipoic acid analogs
US6420342B1 (en) 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
US7128930B1 (en) * 2000-09-01 2006-10-31 Meir S. Sacks Compositions and methods for treating sexual dysfunction
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
ITRM20010621A1 (it) 2001-10-18 2003-04-18 Aldo Fassi Sali metallici non igroscopici e idrosolubili di alcanoil l-carnitine, integratori dietetici che li contengono e kit dietetici, per contrast
WO2003084532A1 (en) * 2002-04-03 2003-10-16 Avery Mitchell A Lipoic acid analogs useful as provitamins and antioxidants
NL1022153C2 (nl) * 2002-12-12 2004-06-15 Tno Cholesterol verlagend preparaat, voedingssupplement en voedingsmiddel en werkwijzen voor de bereiding daarvan.
PT1754478E (pt) * 2005-08-04 2009-03-31 Encrypta Gmbh Composição líquida compreendendo arginina e ácido alfalipóico e sua utilização para melhorar a função sexual

Also Published As

Publication number Publication date
EP1754478B1 (en) 2008-12-31
CY1109430T1 (el) 2014-08-13
JP5295766B2 (ja) 2013-09-18
SI1754478T1 (sl) 2009-06-30
RU2423120C2 (ru) 2011-07-10
EP1754478A1 (en) 2007-02-21
ATE418976T1 (de) 2009-01-15
CN101237862B (zh) 2012-03-21
UA95917C2 (ru) 2011-09-26
CN102670591A (zh) 2012-09-19
DK1909782T3 (da) 2012-08-27
BRPI0614434B8 (pt) 2021-05-25
US20080161381A1 (en) 2008-07-03
MX2008001554A (es) 2008-04-22
WO2007017191A3 (en) 2007-05-24
BRPI0614434B1 (pt) 2020-04-28
JP5925714B2 (ja) 2016-05-25
PL1909782T3 (pl) 2012-12-31
PT1909782E (pt) 2012-08-16
EP1909782B1 (en) 2012-05-16
US9107889B2 (en) 2015-08-18
JP2013136616A (ja) 2013-07-11
DK1754478T3 (da) 2009-05-04
DE602005012089D1 (de) 2009-02-12
SI1909782T1 (sl) 2012-09-28
EP1909782A2 (en) 2008-04-16
CY1113235T1 (el) 2016-04-13
JP2009508810A (ja) 2009-03-05
CN101237862A (zh) 2008-08-06
BRPI0614434A2 (pt) 2011-03-29
JP2016104738A (ja) 2016-06-09
PT1754478E (pt) 2009-03-31
ES2388074T3 (es) 2012-10-08
ES2320560T3 (es) 2009-05-25
RU2008107877A (ru) 2009-09-10
WO2007017191A2 (en) 2007-02-15
CN102670591B (zh) 2014-08-06

Similar Documents

Publication Publication Date Title
CY1113235T1 (el) Συνθεσεις περιλαμβανουσες αργινινη και r-α-λιποϊκο οξυ και χρηση αυτων για βελτιωση της σεξουαλικης λειτουργιας
WO2012092528A8 (en) Treatment of erectile dysfunction and other indications
PT2344130E (pt) Composições tópicas farmacêuticas
MX337166B (es) Composicion topica que contiene ibuoprofeno.
TW200637490A (en) Fertilizer-compatible composition
WO2007062399A3 (en) Oncogenic ras-specific cytotoxic compound and methods of use thereof
WO2005086763A3 (en) Stable injectable compositions
MY160703A (en) Crystalline forms of (r) -5- [3-chloro-4-(2,3-dihydroxy) - benz [z] ylidene] -2- ([z]-propylimino) -3-0-tolyl-thiazolidin-4-one
WO2009109927A3 (en) Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
IL169425A (en) Topical stabilized prostaglandin e compound dosage forms
WO2008132021A3 (de) Fungizide mischungen
WO2007038753A3 (en) Compositions effective to suppress void formation
WO2008070721A3 (en) High protein concentration formulations containing mannitol
WO2008073332A3 (en) Creatine compositions for skin treatment
WO2010019611A3 (en) Bridged polycyclic compound based compositions for topical and oral applications
WO2006133006A3 (en) 1-methyl-1h-pyrazole-4-carboxamides useful as cancer chemotherapeutic agents
SG179405A1 (en) Additive for polishing composition
WO2003004048A1 (en) Compositions for nasal administration of insulin
WO2006089954A3 (en) Compounds for stabilizing factor vii polypeptide formulations
WO2007035718A3 (en) Crystalline forms of the di-sodium salt of n-(5-chlorosalicyloyl)-8-aminocaprylic acid
WO2010048250A3 (en) Anhydrous antiperspirant compositions
WO2008035129A3 (en) The application of the oil fraction obtained from sour cherry (prunus cerasus) seed kernel
WO2010011856A3 (en) Stereospecificity of methylsulfinyl reduction
WO2012004782A3 (en) Oral remedial mineral replenishment (omr) preparation
WO2005112911A3 (en) Compositions and methods for treating myelin deficiency disorders